Recent Drug Developments and Law Update

Recent Drug Developments and Law Update 2021 is Sunday, March 7th Hosted remotely via Zoom

PLEASE NOTE: Due to the pandemic there are no group site locations to attend. This program is being offered as individual continuing education on a personal computer or mobile device.

REGISTRATION CLOSES on Friday, March 5th at 5:00 pm.

    
REGISTRATION
             SCHEDULE  

Presentations - Sunday March 7th, 2021

Description

New drugs and new guideline recommendations continue to affect medical practice.  This program will discuss new therapies for sleep-wake disorders.  Recent guideline updates for the treatment of atrial fibrillation will be presented.  New antibiotic agents will be covered.  Naloxone dispensing under the Montana Standing Order for Naloxone Opioid Antagonists will be discussed.  An update from the Montana Board of Pharmacy and information on the Montana Prescription Drug Registry will also be included.

Goal

The goal of this program is to discuss new drugs, to compare them to other agents in the same pharmacological and/or therapeutic class, and to discuss where these new agents fit into disease state management.  In addition, an update of federal and Montana state pharmacy laws will be provided.

Objectives

At the conclusion of this program, the participant should be able to:

    • Identify and discuss the modifications and updated changes to the Atrial Fibrillation guidelines as described by the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society
    • Discuss management of the risk factors associated with the initiation of and the exacerbation of atrial fibrillation
    • Develop a pharmacotherapy and monitoring plan for a patient with insomnia disorder based on recent guidelines and patient-specific characteristics
    • Recommend appropriate non-pharmacotherapy, pharmacotherapy, medication administration, and monitoring for patients with obstructive sleep apnea or narcolepsy based on recent guidelines and patient-specific characteristics
    • Describe the requirements for dispensing naloxone under the Montana Standing Order
    • Describe how to overcome barriers to dispensing naloxone
    • Describe the requirements and exceptions for use of the Montana Prescription Drug Registry (MPDR) under MCA 37-7-1515, Mandatory Use of Prescription Drug Registry
    • Describe the Interstate Data Sharing enhancement of the Montana Prescription Drug Registry (MPDR)
    • Describe the use of new antibacterial agents in clinical practice
    • Describe the therapeutic potential of antibiotics currently being developed

Activity Type: Knowledge-based

Target Audience: Pharmacists & Pharmacy Technicians (law portion only)

Accreditation Information

ACPE_logo.jpg
Skaggs School of Pharmacy at The University of Montana is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based activity. The Universal Activity Number (UAN) for the Recent Drug Development portion is #0035-0000-21-007-L01-P, and approved for 5 hours or .50 CEUs.  The Universal Activity Number for the Recent Law portion is #0035-0000-21-008-L03-P/T, and approved for 1 hour or .10 CEUs.  In order to receive credits, participants must sign in to the presentation, must view the entire presentation, and complete the program evaluation. CE credits will be uploaded to CPE Monitor within 60-days after the program.

Disclosure

Disclosure of Potential Conflicts of Interest: Skaggs School of Pharmacy at The University of Montana did not receive payment or services from a third party for any aspect of this activity and has no relationships (financial or other) with entities or activities that could be perceived to influence, or that give the appearance of potentially influencing any portion of this activity.

Program Coordinator

Sherrill Brown, DVM, Pharm. D., BCPS
Director, Drug Information Service
The University of Montana, College of Health

Speakers

Vince Colucci, Pharm.D., BCPS, CPP, Professor, University of Montana

Ian McGrane, Pharm.D., BCPS, BCPP, Assistant Professor, University of Montana

Leah Fitch-Brody, Substance Use Disorder Prevention Coordinator, Missoula City-County Health Department

Brandon Vans Arsdale, Missoula City-County Health Department

Tony King, R.Ph., Montana Board of Pharmacy

MaryEllen “Meco” Correia, BSN, RN, CARN, IAAT RN Care Manager, Partnership Health Center

Marcie Bough, Pharm.D., Executive Officer, Montana Board of Pharmacy

Nikki Griffis, Pharm.D., MPDR Program Manager, Montana Board of Pharmacy

Jenner Minto, Pharm.D., University of Montana